Neurotrophic Keratopathy

Neurotrophic Keratopathy is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Neurotrophic Keratitis
Classified under: Eye Disease
Myopathy
Nerve Injury
Nervous System Diseases
Signs and Symptoms
Indicated drugs: Cenegermin

Resolves to

Vocabularies

SNOMED CT128080005MedDRA10069732UMLSC0339296

What you can answer from here — as of November 15, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

29Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Neurotrophic Keratopathy share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.